Dividend Assets Capital, LLC Bristol Myers Squibb CO Transaction History

Dividend Assets Capital, LLC

$519 Million
Q3 2024

A detailed history of Dividend Assets Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dividend Assets Capital, LLC holds 4,219 shares of BMY stock, worth $248,372. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,219

Holding current value

$248,372

% of portfolio

0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $167,325 - $218,333	4,219 New	4,219 $218,000
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $419,825 - $476,000	-8,750 Reduced 60.58%	5,694 $309,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $48,528 - $57,907	-1,001 Reduced 6.48%	14,444 $741,000
Q3 2023 Oct 26, 2023	SELL	$57.89 - $64.73 $237,291 - $265,328	-4,099 Reduced 20.97%	15,445 $896,000
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $47,081 - $52,276	-739 Reduced 3.64%	19,544 $1.25 Million
Q3 2022 Oct 18, 2022	SELL	$0.13 - $76.84 $117 - $69,309	-902 Reduced 4.26%	20,283 $1.44 Million
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $61,727 - $67,983	850 Added 4.18%	21,185 $1.63 Million
Q1 2022 Apr 12, 2022	SELL	$61.48 - $73.72 $144,047 - $172,725	-2,343 Reduced 10.33%	20,335 $1.49 Million
Q3 2021 Nov 01, 2021	SELL	$59.17 - $69.31 $33,726 - $39,506	-570 Reduced 2.45%	22,678 $1.34 Million
Q2 2021 Jul 23, 2021	SELL	$61.91 - $67.42 $36,898 - $40,182	-596 Reduced 2.5%	23,248 $1.55 Million
Q1 2021 Apr 28, 2021	SELL	$59.34 - $66.74 $64,977 - $73,080	-1,095 Reduced 4.39%	23,844 $1.51 Million
Q4 2020 Jan 22, 2021	SELL	$57.74 - $65.43 $92,614 - $104,949	-1,604 Reduced 6.04%	24,939 $1.55 Million
Q3 2020 Oct 19, 2020	SELL	$57.43 - $63.64 $41,636 - $46,139	-725 Reduced 2.66%	26,543 $1.6 Million
Q2 2020 Aug 03, 2020	SELL	$54.82 - $64.09 $80,311 - $93,891	-1,465 Reduced 5.1%	27,268 $1.6 Million
Q1 2020 May 12, 2020	SELL	$46.4 - $67.43 $57,025 - $82,871	-1,229 Reduced 4.1%	28,733 $1.6 Million
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $16,337 - $21,311	-332 Reduced 1.1%	29,962 $1.92 Million
Q3 2019 Oct 25, 2019	SELL	$42.77 - $50.71 $73,564 - $87,221	-1,720 Reduced 5.37%	30,294 $1.54 Million
Q2 2019 Jul 12, 2019	BUY	$44.62 - $49.34 $274,859 - $303,934	6,160 Added 23.83%	32,014 $1.45 Million
Q1 2019 May 02, 2019	BUY	$45.12 - $53.8 $814,145 - $970,767	18,044 Added 231.04%	25,854 $1.23 Million
Q4 2018 Feb 07, 2019	SELL	$48.76 - $63.23 $237,461 - $307,930	-4,870 Reduced 38.41%	7,810 $406,000
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $208,342 - $234,993	-3,775 Reduced 22.94%	12,680 $787,000
Q2 2018 Aug 03, 2018	BUY	$50.53 - $62.98 $1,263 - $1,574	25 Added 0.15%	16,455 $911,000
Q1 2018 May 02, 2018	SELL	$59.92 - $68.98 $81,191 - $93,467	-1,355 Reduced 7.62%	16,430 $1.04 Million
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $6,893 - $7,515	115 Added 0.65%	17,785 $1.09 Million
Q3 2017 Nov 06, 2017	BUY	$55.23 - $63.74 $975,914 - $1.13 Million	17,670	17,670 $1.13 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dividend Assets Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dividend Assets Capital, LLC with notifications on news.

Account

Dividend Assets Capital, LLC Bristol Myers Squibb CO Transaction History